Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227]
1 Division of Metabolic Disorders, Children's Hospital of Orange County, 1201 W. La Veta Ave, Orange, CA 92868, United States; Department of Pediatrics, University of California-Irvine, Orange, CA 92868, United States. Electronic address: [email protected].
2 Hospital Sabara, Av. Angélica, 1987 Consolação, São Paulo, SP 01227-200, Brazil; Centro de Biotecnologia, Instituto de Pesquisas de Energéticas e Nucleares IPEN/USP, Av 11 de junho 364, Casa 3, Vila Clementino, São Paulo 04041-001, Brazil.
3 Centenario Hospital Miguel Hidalgo, Av. Gomez Morin S/N, La estación- La Alameda, Aguascalientes Ags 20259, Mexico.
4 Centro Hospitalar Do Porto, Hospital de Santo António, Porto, Largo do Prof. Abel Salazar, 4099-001 Porto, Portugal.
5 Department of Molecular & Human Genetics Baylor College of Medicine, Texas Children's Hospital, Mail Stop BCM225, Houston, TX 77030, United States. Electronic address: [email protected].
6 Department of Pediatrics, and Experimental and Clinical Pharmacology, University of Minnesota, East Building, 2450 Riverside Ave, Minneapolis, MN 55454, United States. Electronic address: [email protected].
7 Ultragenyx Pharmaceutical Inc., 60 Leveroni Ct, Novato, CA 94949, United States. Electronic address: [email protected].
8 Ultragenyx Pharmaceutical Inc., 60 Leveroni Ct, Novato, CA 94949, United States. Electronic address: [email protected].
9 Ultragenyx Pharmaceutical Inc., 60 Leveroni Ct, Novato, CA 94949, United States. Electronic address: [email protected].
10 Ultragenyx Pharmaceutical Inc., 60 Leveroni Ct, Novato, CA 94949, United States. Electronic address: [email protected].
11 UCSF Benioff Children's Hospital Oakland, 744 52nd St, Oakland, CA 94609, United States. Electronic address: [email protected].